GMP Consulting Services
Guiding You Through Every Step of the Manufacturing Cycle by Expert Consulting Solutions
Utilize our unified GMP consultancy services to ensure compliance and quality throughout the entire manufacturing cycle
We offer a complete GMP consulting services designed to help your organization to achieve and maintain highest global standards of quality compliance.
Consultation & Support Services
Zenovel is a reliable GMP consultant for pharmaceutical companies worldwide, offering a comprehensive range of services on a convenient platform. We provide scientific guidance and cost-effective solutions, thanks to our professionally developed SOPs, documentation, and knowledgeable staff. This ensures the most effective and efficient GMP consulting services.
We are specialists in product quality for the regulated life sciences sector, including pharmaceuticals, biotech, and medical devices. Our services cover the entire product development lifecycle, from raw materials to patient delivery. We offer consulting and advising services like quality management systems, mock inspections, equipment certification, computerized system validation, and plant engineering evaluations, tailored to each customer’s unique needs.
- What can you expect from Zenovel Consulting Services?
- Why Choose Zenovel ?
- Skilled and Knowledgeable Professionals
Our consultants, with extensive experience in Regulatory compliance consulting
and quality management, offer crucial support to ensure your organization adheres to the highest GMP standards.
- Risk based Solution Approach
We employ a tailored solution for efficient management such as mitigation approaches, risk assessment, prioritization, continuous monitoring strategies based on identified risks.
- High Credibility
The company’s success is attributed to its extensive experience, meticulous attention to detail, and successful regulatory compliance solutions.
- Strong Value System
We ensure integrity, transparency, and commitment to ethical standards in all areas.
Blogs and news
Our Latest Article
India is a significant player in the global pharmaceuticals sector, characterized by a diverse population and cost-effective infrastructure. However, its potential in clinical research is hindered by complex regulatory challenges that delay innovations and deter investment, affecting the timely market introduction of life-saving drugs. This blog discusses the major obstacles
The FDA issued 466 Form 483s to drug organizations in FY 2022, more than double the previous year, highlighting significant quality failures in the pharmaceutical sector. For startups and scale-ups seeking market approval, the excitement of innovation often conflicts with the strict requirements of current good manufacturing practices (cGMP). Although
Introduction Liposomal Amphotericin-B is a critical antifungal medication that requires careful attention during Bioequivalence (BE) studies. These studies aim to demonstrate the similarity of a generic liposomal Amphotericin B formulation to the reference drug in terms of pharmacokinetics. Zenovel, with its extensive experience in monitoring Amphotericin B studies, can play
In the pharmaceutical and biotechnology industries, obtaining regulatory approval is essential prior to introducing new drugs or biologics to the market. A pivotal aspect of this approval process is the FDA Pre-Approval Inspection (PAI), which involves a comprehensive assessment of manufacturing facilities, processes, and data integrity to ensure adherence to
Risk Based Monitoring (RBM) is a more efficient alternative to traditional clinical trials, focusing on high-risk areas through data-driven insights. It ensures patient safety, data integrity, and regulatory compliance while reducing costs and timelines. However, the success of RBM depends on the competency of monitors, who identify risks, analyze data,
Welcome to the Zenovel Blog! We are a leading provider of drug regulatory consulting and education, focusing on advancing pharmaceutical innovation while ensuring safety and compliance. This blog delves into the essentials of Drug Regulatory Affairs (DRA), covering its scope, career opportunities, and intricate processes involved in bringing new drugs
